Single center experience and early outcomes of Impella 5.5.

Masaki Funamoto,Chandra Kunavarapu,Michael D Kwan,Yuichi Matsuzaki,Mahek Shah,Masahiro Ono

Frontiers in cardiovascular medicine（2023）

Cited 3|Views10

No score

Abstract

Our results suggest that Impella 5.5 provides favorable survival in the management of HF and CS, particularly used for a bridge to heart transplant or LVAD. Early extubation and mobilization with high flow circulatory support allowed effective tailoring of MCS approaches from peri-operative support for high-risk cardiac surgery, bridge to recovery, and to advanced surgical heart failure therapy.

Translated text

Key words

Impella,bridge to LVAD,bridge to recovery,bridge to transplant,cardiogenic shock,high risk cardiac surgery,temporary mechanical circulatory support

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined